Corporate News
Cencora Inc, a pharmaceutical company providing commercialization solutions and healthcare products, has reported a significant increase in its stock price over the past year. According to available data, investors who invested $1,000 in the company a year ago now hold shares worth over $1,200.
This represents a growth of 21.1% in a year, calculated as follows:
- Initial investment: $1,000
- Current value: $1,200
- Growth rate: (Current value - Initial investment) / Initial investment = ($1,200 - $1,000) / $1,000 = 0.2 or 20%
- Annual growth rate: 20% / year = 21.1% (rounded to one decimal place)
The company’s market value has also risen, with Cencora being valued at over $55 billion.